$750 million has been agreed to be paid by GlaxoSmithKline, one of the world’s largest pharmaceutical makers, to settle a Justice Department lawsuit accusing the company of selling adulterated and improperly made drugs, federal officials say. This settlement is the result of a long-running federal investigation of the company’s former drug manufacturing plant in Cidra, Puerto Rico. “The government claimed that the plant churned out medications that were mislabeled, mixed up in the wrong packaging, and even defective – made either too weak or too strong. The allegations included such popular prescription drugs as Paxil and Avandia.” “We regret that we operated the Cidra facility in a manner that was inconsistent with current Good Manufacturing Practice (cGMP) requirements and with GSK’s commitment to manufacturing quality,” PD Villarreal, GSK’s senior vice president and head of global litigation said in a statement Tuesday. “GSK worked hard to resolve fully the manufacturing issues at the Cidra facility prior to its closure in 2009 and we are committed to continuous improvement in our manufacturing processes.” The Justice Department’s original lawsuit claimed that the plant mixed different strengths of some pills together, such as both 30 mg and 10 mg tablets in the same bottle. The government also claimed that some drugs were contaminated with micro-organisms, including an ointment used to treat skin infections in small children and an injectable drug for treating nausea in patients undergoing chemotherapy.
$750 Million to be Paid by Drug Maker for Defective Drugs
October 26, 2010 By Leave a Comment
Speak Your Mind
You must be logged in to post a comment.